Literature DB >> 499706

Cholesterol and bile acid metabolism in moderately advanced, stable cirrhosis of the liver.

K von Bergmann, H Y Mok, W G Hardison, S M Grundy.   

Abstract

We have selected for this study a well-defined group of patients with moderately advanced but compensated alcoholic cirrhosis. They were well-nourished and had no ascites, varices, azotemia, or encephalopathy. Liver biopsy showed little or no necrosis and inflammation despite wide-spread fibrosis. Serum bilirubin, transaminase, alkaline phosphatase, albumin and globulins were essentially normal. Biochemical evidence for liver disease was restricted to modest elevation of BSP retention, gamma GTP, serum bile acid concentrations, and urinary bile acid excretion. Except for changes in the interrelationships among the three biliary lipids, they were generally spared the abnormalities of sterol metabolism described in other patients with more advanced, more active liver disease. Thus, striking abnormalities in the metabolism of cholesterol and bile acids probably require severe reductions in functioning hepatocellular mass, major portal-systemic shunting, high disease activity, or all three to become manifest.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 499706

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

1.  Delineation of biochemical, molecular, and physiological changes accompanying bile acid pool size restoration in Cyp7a1(-/-) mice fed low levels of cholic acid.

Authors:  Ryan D Jones; Joyce J Repa; David W Russell; John M Dietschy; Stephen D Turley
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-05-24       Impact factor: 4.052

2.  Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance.

Authors:  S M Grundy; D W Bilheimer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

3.  Hypocalcemia and steatorrhea--clues to etiology.

Authors:  J E Heubi; J C Partin; W K Schubert
Journal:  Dig Dis Sci       Date:  1983-02       Impact factor: 3.199

4.  Biliary lipids, faecal steroids, and liver function in patients with chronic active hepatitis and primary biliary cirrhosis: significance of hepatic orcein-stained complexes.

Authors:  Y A Kesäniemi; T A Miettinen; M P Salaspuro
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

5.  Serum, fecal and urinary bile acids in patients with mild and advanced liver cirrhosis.

Authors:  Y Amuro; T Endo; K Higashino; K Uchida; Y Yamamura
Journal:  Gastroenterol Jpn       Date:  1981

6.  Effect of Rowachol on biliary lipid secretion and serum lipids in normal volunteers.

Authors:  O Leiss; K von Bergmann
Journal:  Gut       Date:  1985-01       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.